Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele

Prenatal Diagnosis

Volumn 28, Issue 13, 2008, Pages 1204-1208

  Hoffman, Jodi D ^a   Bianchi, Diana W ^a   Sullivan, Lisa M ^b   Mackinnon, Brenda L ^a   Collins, Jamie ^b   Malone, Fergal D ^c   Porter, T Flint ^d   Nyberg, David A ^e   Comstock, Christine H ^f   Bukowski, Radek ^g   Berkowitz, Richard L ^c,h   Gross, Susan J ⁱ   Dugoff, Lorraine ^j   Craigo, Sabrina D ^a   Timor Tritsch, Ilan E ^k   Carr, Stephen R ^l   Wolfe, Honor M ^m   D'Alton, Mary E ^c  

^a TUFTS MEDICAL CENTER   (United States)

^b DM STAT Inc   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d INTERMOUNTAIN HEALTHCARE   (United States)

^e SWEDISH MEDICAL CENTER   (United States)

^f WILLIAM BEAUMONT HOSPITAL   (United States)

^g UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF COLORADO   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l BROWN UNIVERSITY   (United States)

^m UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

more..

Author keywords

FASTER trial; Hydrocele; Multicystic dysplastic kidney; Serum screening; Two vessel cord

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ANEUPLOIDY; ARTICLE; BLOOD EXAMINATION; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOWN SYNDROME; FEMALE; HUMAN; HYDROCELE; MULTICYSTIC DYSPLASTIC KIDNEY; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; TWO VESSEL CORD; UMBILICAL MALFORMATION;

ADULT; ALPHA-FETOPROTEINS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; DOWN SYNDROME; ESTRIOL; FEMALE; HUMANS; INFANT, NEWBORN; INHIBINS; MALE; MULTICYSTIC DYSPLASTIC KIDNEY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; TESTICULAR HYDROCELE;

EID: 58049212021     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2082     Document Type: Article

References (11)

1. Aitken DA, Ireland M, Berry E, et al. 1999. Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies. Prenat Diagn 19: 706-710.
2. Begleiter ML, Lund MM, Atherton AM, Buchholz JD, Ardinger HH. 2007. Maternal serum screening and 22q11.2 deletion syndrome. Am J Med Genet A 143A: 410-411.
3. Bradley LA, Palomaki GE, Knight GJ, et al. 1999. Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses. Am J Med Genet A 82A: 355-358.
4. Canick JA, Abuelo DN, Bradley LA, Tint GS. 1997. Maternal serum marker levels in two pregnancies affected with Smith-Lemli-Opitz syndrome. Prenat Diagn 17: 187-189.
5. Celentano C, Guanciali-Franchi PE, Liberati M, et al. 2005. Lack of correlation between elevated maternal serum hCG during second trimester biochemical screening and fetal congenital anomaly. Prenat Diagn 25: 220-224.
6. Craig WY, Haddow JE, Palomaki GE, et al. 2006. Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome. Prenat Diagn 26: 842-849.
7. Dugoff L, Hobbins JC, Malone FD, et al. 2005. The quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 106: 260-267.
8. Malone FD, Ball RH, Nyberg DA, et al, FASTER Trial Research Consortium. 2005a. First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol 106: 288-294.
9. Malone FD, Canick JA, Ball RH, et al, First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. 2005b. First-trimester or second-trimester screening, or both, for Down syndrome. N Engl J Med 353: 2001-2011.
10. nd trimester screening for Down's syndrome. J Med Screen 9: 43-44.
11. Tint GS, Abuelo D, Till M, et al. 1998. Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols. Prenat Diagn 18: 651-658.